Literature DB >> 11744749

Mexiletine block of disease-associated mutations in S6 segments of the human skeletal muscle Na(+) channel.

M P Takahashi1, S C Cannon.   

Abstract

1. Over twenty different missense mutations in the alpha-subunit of the adult skeletal muscle Na(+) channel (hSkM1) have been identified as a cause of myotonia or periodic paralysis. We examined state-dependent mexiletine block for mutations involving the putative binding site in S6 segments (V445M, S804F, V1293I, V1589M and M1592V). Whole-cell Na(+) currents were measured from wild-type (WT) and mutant channels transiently expressed in HEK cells. 2. Use-dependent block (10 ms pulses to -10 mV, at 20 Hz) in 100 microM mexiletine was reduced modestly by mutations in IVS6 (V1589M, M1592V) and enhanced by the mutation in IS6 (V445M). For mutations in IIS6 (S804F) and IIIS6 (V1293I) use-dependent block was not statistically different from that of wild-type channels. 3. Resting-state block (10 ms pulses to -10 mV from -150 mV, at 0.1 Hz) of S6 mutants was comparable to that of WT (dissociation constant for resting channels, K(R) = 650 +/- 40 microM, n = 9). The S6 mutant with the greatest change in K(R) was V445M (K(R) = 794 +/- 45 microM, n = 5), but this difference was only marginally significant (P = 0.047). 4. A modified technique for estimating local anaesthetic affinity of inactivated channels was developed to reduce errors due to slow inactivation and to failure of drug binding to reach equilibrium. Mexiletine affinity for inactivated channels was reduced by mutations in IVS6 (V1589M: dissociation constant for the inactivated state (K(I)) = 44.7 microM; M1592V: K(I) = 40.0 microM) and increased by the mutation in IS6 (V445M: K(I) = 15.0 microM), compared to wild-type channels (K(I) = 28.3 microM). 5. We conclude that the disease-associated S6 mutations in domains I-IV cause at most a 2-fold change in inactivated state affinity and have even less of an effect on resting block. Model simulations show that the reduced use-dependent block of IVS6 mutants derives primarily from an increased off-rate at hyperpolarized potentials, whereas the enhanced use-dependent block of the IS6 mutant was due to a higher affinity for inactivated V445M channels.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11744749      PMCID: PMC2278988          DOI: 10.1111/j.1469-7793.2001.00701.x

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  37 in total

Review 1.  Molecular mechanisms of local anesthesia: a review.

Authors:  J F Butterworth; G R Strichartz
Journal:  Anesthesiology       Date:  1990-04       Impact factor: 7.892

Review 2.  Voltage-gated ion channels and hereditary disease.

Authors:  F Lehmann-Horn; K Jurkat-Rott
Journal:  Physiol Rev       Date:  1999-10       Impact factor: 37.312

Review 3.  Mexiletine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in the treatment of arrhythmias.

Authors:  J P Monk; R N Brogden
Journal:  Drugs       Date:  1990-09       Impact factor: 9.546

4.  The cloning and expression of a sodium channel beta 1-subunit cDNA from human brain.

Authors:  A I McClatchey; S C Cannon; S A Slaugenhaupt; J F Gusella
Journal:  Hum Mol Genet       Date:  1993-06       Impact factor: 6.150

5.  Theoretical reconstruction of myotonia and paralysis caused by incomplete inactivation of sodium channels.

Authors:  S C Cannon; R H Brown; D P Corey
Journal:  Biophys J       Date:  1993-07       Impact factor: 4.033

6.  Molecular determinants of state-dependent block of Na+ channels by local anesthetics.

Authors:  D S Ragsdale; J C McPhee; T Scheuer; W A Catterall
Journal:  Science       Date:  1994-09-16       Impact factor: 47.728

7.  Functional consequences of a Na+ channel mutation causing hyperkalemic periodic paralysis.

Authors:  T R Cummins; J Zhou; F J Sigworth; C Ukomadu; M Stephan; L J Ptácek; W S Agnew
Journal:  Neuron       Date:  1993-04       Impact factor: 17.173

8.  Primary structure of the adult human skeletal muscle voltage-dependent sodium channel.

Authors:  A L George; J Komisarof; R G Kallen; R L Barchi
Journal:  Ann Neurol       Date:  1992-02       Impact factor: 10.422

9.  Paramyotonia congenita: abnormal short exercise test, and improvement after mexiletine therapy.

Authors:  C E Jackson; R J Barohn; L J Ptacek
Journal:  Muscle Nerve       Date:  1994-07       Impact factor: 3.217

10.  Lidocaine block of cardiac sodium channels.

Authors:  B P Bean; C J Cohen; R W Tsien
Journal:  J Gen Physiol       Date:  1983-05       Impact factor: 4.086

View more
  21 in total

Review 1.  Inherited disorders of voltage-gated sodium channels.

Authors:  Alfred L George
Journal:  J Clin Invest       Date:  2005-08       Impact factor: 14.808

2.  Speeding the recovery from ultraslow inactivation of voltage-gated Na+ channels by metal ion binding to the selectivity filter: a foot-on-the-door?

Authors:  Julia Szendroedi; Walter Sandtner; Touran Zarrabi; Eva Zebedin; Karlheinz Hilber; Samuel C Dudley; Harry A Fozzard; Hannes Todt
Journal:  Biophys J       Date:  2007-08-24       Impact factor: 4.033

3.  Mexiletine is an effective antimyotonia treatment in myotonic dystrophy type 1.

Authors:  E L Logigian; W B Martens; R T Moxley; M P McDermott; N Dilek; A W Wiegner; A T Pearson; C A Barbieri; C L Annis; C A Thornton; R T Moxley
Journal:  Neurology       Date:  2010-05-04       Impact factor: 9.910

4.  Rapid protein kinase C-dependent reduction of rat skeletal muscle voltage-gated sodium channels by ciliary neurotrophic factor.

Authors:  S Talon; M-A Giroux-Metges; J-P Pennec; C Guillet; H Gascan; M Gioux
Journal:  J Physiol       Date:  2005-04-14       Impact factor: 5.182

5.  Mexiletine for treatment of myotonia: a trial triumph for rare disease networks.

Authors:  Eric P Hoffman; Henry J Kaminski
Journal:  JAMA       Date:  2012-10-03       Impact factor: 56.272

6.  Bupivacaine blocks N-type inactivating Kv channels in the open state: no allosteric effect on inactivation kinetics.

Authors:  Johanna Nilsson; Michael Madeja; Fredrik Elinder; Peter Arhem
Journal:  Biophys J       Date:  2008-09-12       Impact factor: 4.033

7.  Different flecainide sensitivity of hNav1.4 channels and myotonic mutants explained by state-dependent block.

Authors:  Jean-François Desaphy; Annamaria De Luca; Maria Paola Didonna; Alfred L George; Diana Camerino Conte; Annamaria D E Luca
Journal:  J Physiol       Date:  2003-11-07       Impact factor: 5.182

8.  Mexiletine block of wild-type and inactivation-deficient human skeletal muscle hNav1.4 Na+ channels.

Authors:  Ging Kuo Wang; Corinna Russell; Sho-Ya Wang
Journal:  J Physiol       Date:  2003-11-07       Impact factor: 5.182

9.  Outward stabilization of the S4 segments in domains III and IV enhances lidocaine block of sodium channels.

Authors:  Michael F Sheets; Dorothy A Hanck
Journal:  J Physiol       Date:  2007-05-17       Impact factor: 5.182

Review 10.  Treatment of neuromuscular channelopathies: current concepts and future prospects.

Authors:  James C Cleland; Robert C Griggs
Journal:  Neurotherapeutics       Date:  2008-10       Impact factor: 7.620

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.